Center-Authored Papers

Filters: Author is Agura, Edward  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
Sorror ML, Storer BE, Sandmaier BM, Maris M, Shizuru J, Maziarz R, Agura E, Chauncey TR, Pulsipher MA, McSweeney PA et al..  2008.  Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(30):4912-20. Abstract
H
Sorror ML, Maris MB, Sandmaier BM, Storer BE, Stuart MJ, Hegenbart U, Agura E, Chauncey TR, Leis J, Pulsipher M et al..  2005.  Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(16):3819-29. Abstract
I
Bachanova V, Burns LJ, Woo Ahn K, Laport GG, Akpek G, Kharfan-Dabaja MA, Nishihori T, Agura E, Armand P, Jaglowski SM et al..  2015.  Impact of pre-transplant FDG-PET status on outcomes after allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
L
Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR, Agura E, Maziarz RT, Langston A, Hari P et al..  2011.  Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.. JAMA : the journal of the American Medical Association. 306(17):1874-83. Abstract
N
Rezvani AR, Norasetthada L, Gooley TA, Sorror ML, Bouvier ME, Sahebi F, Agura E, Chauncey TR, Maziarz RT, Maris M et al..  2008.  Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.. British journal of haematology. 143(3):395-403. Abstract
Gyurkocza B, Storb R, Storer BE, Chauncey TR, Lange T, Shizuru JA, Langston AA, Pulsipher MA, Bredeson CN, Maziarz RT et al..  2010.  Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(17):2859-67. Abstract
Rezvani AR, Storer BE, Maris M, Sorror ML, Agura E, Maziarz RT, Wade JC, Chauncey TR, Forman SJ, Lange T et al..  2008.  Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(2):211-7. Abstract
P
Bredeson C, Le Rademacher J, Kato K, Dipersio JF, Agura E, Devine SM, Appelbaum FR, Tomblyn MR, Laport GG, Zhu X et al..  2013.  Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation.. Blood. Abstract
R
Kahl C, Storer BE, Sandmaier BM, Mielcarek M, Maris MB, Blume KG, Niederwieser D, Chauncey TR, Forman SJ, Agura E et al..  2007.  Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.. Blood. 110(7):2744-8. Abstract